Skip to main content
AI News List

List of AI News about Scripps Research

Time Details
2026-11-20
14:13 UTC
OpenAI debuts GPT-Rosalind to advance neurodegenerative R&D

According to OpenAI via X, GPT-Rosalind is being used with PerturbAI and Scripps Research to surface new leads for understanding and treating neurodegenerative diseases.

Source
2026-11-20
14:00 UTC
OpenAI GPT-Rosalind flags cholesterol transport as neuro target

According to OpenAI, GPT-Rosalind linked DCTN1 disruption to altered cholesterol pathways in mouse brain data and proposed restoring cholesterol transport as a testable neurodegeneration therapy lead, synthesized by thousands of agents in 32 minutes with PerturbAI and Scripps Research.

Source
2026-10-21
08:53 UTC
OpenAI GPT-Rosalind finds cholesterol transport lead in neurons

According to OpenAI via Greg Brockman and the linked OpenAI blog, GPT-Rosalind mapped mouse-brain gene expression in 32 minutes to propose impaired cholesterol transport as a testable mechanism tied to DCTN1 and Perry syndrome, highlighting new neurodegeneration drug targets with PerturbAI and Scripps Research.

Source
2026-10-21
05:32 UTC
OpenAI’s GPT-Rosalind flags DCTN1 cholesterol transport lead

According to OpenAI, GPT-Rosalind linked DCTN1 disruption to elevated cholesterol synthesis genes in mouse brain data and proposed impaired cholesterol transport as a testable mechanism for neurodegeneration.

Source